STYLE. COMMUNITY. GREAT CLOTHING.
Bored of counting likes on social networks? At Styleforum, you’ll find rousing discussions that go beyond strings of emojis.
Click Here to join Styleforum's thousands of style enthusiasts today!
Styleforum is supported in part by commission earning affiliate links sitewide. Please support us by using them. You may learn more here.
Amazon has been on a tear lately. Almost 40% since August.
Why sell at the low point? It's the first time in a long while that valuations aren't looking crazy high.Biotech as a whole isn't looking too hot right now.
I should get out and eat my losses (30%+)
I think that is a misinterpretation of the business model. List prices are raised, gross prices are very different. As Mike Pearson has said in the last earnings call, buying mispriced assets isn't really in the business model going forward. It hasn't really been part of the strategy over the last few years either.Brah that's my style -- buy high and sell low.
lol in all seriousness I'm just not liking the senatorial probe into drug pricing. That's a probe into your guys' fundamental business model of acquiring drugs and boosting prices.
No bueno.. I don't see how this ends well.
I'm willing to bet the probe goes nowhere.